The oncology landscape is experiencing a dramatic transformation as a wave of groundbreaking drug approvals emerges across the field. These innovative therapies, targeting specific pathways within cancer cells, offer optimistic results for patients battling a spectrum of devastating diseases. Clinical trials have demonstrated significant increases